Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$696M |
| 2 |
Moderna
MRNA
|
+$487M |
| 3 |
Analog Devices
ADI
|
+$272M |
| 4 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$261M |
| 5 |
Tesla
TSLA
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$670M |
| 2 |
Microsoft
MSFT
|
+$376M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$335M |
| 4 |
Alibaba
BABA
|
+$323M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.45% |
| 2 | Healthcare | 13.43% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 10.66% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
First Bank
FRBA
$471M
| $847K | ﹤0.01% |
60,136
+3,277
| +6% | +$43.7K |
|
|
ATNX
3452
DELISTED
Athenex, Inc. Common Stock
ATNX
| $844K | ﹤0.01% |
14,027
+927
| +7% | +$67.5K |
|
3453
Greenlight Captial
GLRE
$505M
| $842K | ﹤0.01% |
113,980
+4,871
| +4% | +$40.7K |
|
3454
Black Diamond Therapeutics
BDTX
$121M
| $841K | ﹤0.01% |
99,384
+17,889
| +22% | +$177K |
|
3455
Puma Biotechnology
PBYI
$450M
| $839K | ﹤0.01% |
119,681
+6,913
| +6% | +$51.8K |
|
3456
Mistras Group
MG
$556M
| $837K | ﹤0.01% |
82,294
+5,561
| +7% | +$54.9K |
|
3457
National Bankshares
NKSH
$271M
| $835K | ﹤0.01% |
22,990
-160
| -0.7% | -$5.83K |
|
3458
Parke Bancorp
PKBK
$409M
| $835K | ﹤0.01% |
38,114
-350
| -0.9% | -$7.13K |
|
3459
Duluth Holdings
DLTH
$151M
| $833K | ﹤0.01% |
61,124
+2,174
| +4% | +$34.7K |
|
|
EIGR
3460
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $833K | ﹤0.01% |
4,162
+313
| +8% | +$74.4K |
|
|
CANO
3461
DELISTED
Cano Health, Inc.
CANO
| $833K | ﹤0.01% |
+657
| New | +$796K |
|
3462
Korro Bio
KRRO
$197M
| $832K | ﹤0.01% |
2,357
+168
| +8% | +$66.1K |
|
3463
Bioventus
BVS
$1.17B
| $830K | ﹤0.01% |
58,631
+41,113
| +235% | +$633K |
|
|
HGEN
3464
DELISTED
HUMANIGEN, INC.
HGEN
| $830K | ﹤0.01% |
140,077
+5,191
| +4% | +$72.9K |
|
3465
INNOVATE Corp
VATE
$105M
| $828K | ﹤0.01% |
20,200
+682
| +3% | +$25.5K |
|
|
CASA
3466
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $828K | ﹤0.01% |
122,192
+6,453
| +6% | +$47.6K |
|
3467
Annovis Bio
ANVS
$76.1M
| $826K | ﹤0.01% |
26,036
+3,868
| +17% | +$222K |
|
3468
Cytek Biosciences
CTKB
$636M
| $826K | ﹤0.01% |
+38,569
| New | +$907K |
|
|
ERF
3469
DELISTED
Enerplus Corporation
ERF
| $826K | ﹤0.01% |
103,259
-36,901
| -26% | -$229K |
|
|
ESTE
3470
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $826K | ﹤0.01% |
89,855
+5,792
| +7% | +$53.2K |
|
|
TBNK
3471
DELISTED
Territorial Bancorp Inc.
TBNK
| $825K | ﹤0.01% |
32,521
-217
| -0.7% | -$5.5K |
|
3472
WisdomTree True Developed International Fund
DOL
$848M
| $824K | ﹤0.01% |
17,335
+9,286
| +115% | +$462K |
|
3473
Vor Biopharma
VOR
$1.32B
| $819K | ﹤0.01% |
2,613
+915
| +54% | +$272K |
|
|
VINC
3474
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $818K | ﹤0.01% |
2,529
+1,928
| +321% | +$562K |
|
|
HYRE
3475
DELISTED
HyreCar Inc. Common Stock
HYRE
| $818K | ﹤0.01% |
96,220
+8,505
| +10% | +$116K |
|
Similar funds
Bank of New York Mellon's Q3 2021 Portfolio in Review
As of Q3 2021, Bank of New York Mellon held 4,634 positions worth $512B, down 0.89% from $517B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bank of New York Mellon's Q3 2021 filing shows 243 new, 2,575 increased, 1,388 reduced and 114 closed positions. Its largest new stake was GXO Logistics: 863,863 shares worth $67.8M. The largest sale was Apple, an estimated $670M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q3 2021 buy was GXO Logistics: 863,863 shares worth $67.8M.
- Bank of New York Mellon added most to Vanguard S&P 500 ETF in Q3 2021, an estimated $696M increase.
- Bank of New York Mellon's biggest Q3 2021 reduction was Apple, cutting an estimated $670M.
- Bank of New York Mellon fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $335M.
- Bank of New York Mellon's ten largest holdings make up 20% of its $512B portfolio in Q3 2021.
- Bank of New York Mellon opened 243 new positions and closed 114 in Q3 2021.
- Bank of New York Mellon's portfolio value fell 0.89% quarter-over-quarter to $512B.
Based on Bank of New York Mellon's 13F filing for Q3 2021, filed 12 Nov 2021.